208 related articles for article (PubMed ID: 31027734)
21. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
23. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
[TBL] [Abstract][Full Text] [Related]
24. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.
Mei YP; Zhou JM; Wang Y; Huang H; Deng R; Feng GK; Zeng YX; Zhu XF
Cell Cycle; 2007 Jun; 6(11):1379-85. PubMed ID: 17507800
[TBL] [Abstract][Full Text] [Related]
25. Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
Chew MM; Gan SY; Khoo AS; Tan EL
BMC Cancer; 2010 Oct; 10():574. PubMed ID: 20964870
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
[TBL] [Abstract][Full Text] [Related]
27. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW
Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126
[TBL] [Abstract][Full Text] [Related]
29. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
Liu JP; Cassar L; Pinto A; Li H
Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
[TBL] [Abstract][Full Text] [Related]
31. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
[TBL] [Abstract][Full Text] [Related]
32. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT
Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603
[TBL] [Abstract][Full Text] [Related]
33. PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells.
Lai XF; Shen CX; Wen Z; Qian YH; Yu CS; Wang JQ; Zhong PN; Wang HL
J Exp Clin Cancer Res; 2012 Feb; 31(1):12. PubMed ID: 22316341
[TBL] [Abstract][Full Text] [Related]
34. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
[TBL] [Abstract][Full Text] [Related]
35. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells.
Dutton A; Woodman CB; Chukwuma MB; Last JI; Wei W; Vockerodt M; Baumforth KR; Flavell JR; Rowe M; Taylor AM; Young LS; Murray PG
Blood; 2007 Mar; 109(6):2597-603. PubMed ID: 17148591
[TBL] [Abstract][Full Text] [Related]
36. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.
Shi F; Shang L; Zhou M; Lv C; Li Y; Luo C; Liu N; Lu J; Tang M; Luo X; Xu J; Fan J; Zhou J; Gao Q; Wu W; Jia W; Wang H; Cao Y
J Med Virol; 2024 May; 96(5):e29634. PubMed ID: 38682578
[TBL] [Abstract][Full Text] [Related]
40. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
